Aurobindo Pharma receives USFDA approval for Rivastigmine Tartrate
Aurobindo Pharma has received final USFDA to manufacture and market Rivastigmine Tartrate Capsules USP which is used for the treatment of dementia disease, in the […]
FDA
Aurobindo Pharma receives USFDA approval for valganciclovir
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Cadila Healthcare receives USFDA approval for Acylovir capsules
Cadila Healthcare has received USFDA approval for its anti-viral generic drug Acyclovir capsules Acyclovir capsules to market the same in the American market. The drug […]
Aurobindo Pharma receives USFDA approval for Levofloxacin injection,
Aurobindo Pharma has received final USFDA approval to manufacture and market Levofloxacin injection, an anti-infective used in the treatment of bacterial infection in adults in […]
Dr. Reddys Lab receives USFDA approval for Sernivo spray
Dr. Reddys Laboratories through its subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder. The drug Sernivo […]
Aurobindo Pharma receives USFDA approval for Demedetomidine
Aurobindo Pharma has received final USFDA approval to manufacture and market pre- surgery sedation injections Dexmedetomidine Hydrochloride in 200 mcg (base)/2 mL (100 mcg (base)/mL) […]
Orchid Pharma receives USFDA approval for rasagiline tablet
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Glenmark Pharma receives USFDA approval for oral contraceptive ethinyl estradiol tablets
Glenmark Pharmaceuticals has received the final USFDA approval for its generic oral contraceptive norgestimate ethinyl estradiol tablets. in strengths of 0.18 mg/0.025 mg, 0.215 mg/ […]
Zydus Cadila receives USFDA approval for Glyburide and Metformin HCL tablets
Zydus Cadila has received final USFDA approval to sell anti-diabetics Glyburide and Metformin Hcl tablets in in strengths of 1.25/250, 2.5/500 and 5/500 mg in […]
Glenmark Pharma receives USFDA approval for Frovatriptan Succinate
Glenmark Pharma has received USFDA approval to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets, used to treat migraine headaches. The drug Frovatriptan […]